Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on November 2, 2017. The filing primarily addresses two events: the announcement of financial results for the quarter ended September 30, 2017, and the execution of a definitive agreement to acquire Premier Health Plan, Inc.
Key Financial Metrics and Transaction Details
The filing references a press release (Exhibit 99.1) containing the specific financial results for the quarter ended September 30, 2017, but the text of this 8-K does not explicitly state revenue, profit, cash flow, or margin figures.
Regarding the acquisition of Premier Health Plan:
- Transaction Type: Acquisition of 100% of the stock of Premier Health Plan, Inc.
- Consideration: A combination of cash and shares of Evolent Health Class A common stock.
- Estimated Purchase Price: Approximately $31.0 million, based on current membership levels.
- Pricing Mechanism: Final price determined at closing based on the number of certain members and subject to post-closing adjustments.
- Target Business: Premier Health Plan's Medicare Advantage, commercial, and administrative services businesses conducted in Ohio.
Material Changes and Strategic Agreements
On October 31, 2017, Evolent Health, Inc. and related entities entered into a Stock Purchase Agreement to acquire Premier Health Plan. This represents a material expansion of the Company's operations into the Ohio market.
Concurrent with the acquisition, the following strategic arrangements were established:
- Strategic Agreement: Evolent Health, LLC will serve as a strategic partner for Premier Parent's CMS Medicare Shared Savings programs and payer partnerships.
- Administrative Services Agreement: Premier Health Plan will perform administrative services for Premier Parent.
- Provider Arrangement: A long-term agreement for Premier Parent's hospitals and physicians to provide medical services to Premier Business members.
Guidance, Outlook, and Risks
Closing Timeline: The transaction is expected to close in the first quarter of 2018.
Conditions Precedent: Closing is subject to customary conditions, including federal and state regulatory approvals.
Risks and Contingencies: The filing includes forward-looking statements regarding the acquisition. Key risks include the possibility that the closing may be delayed or not occur due to regulatory hurdles, litigation, or other matters. The Company disclaims any obligation to update these forward-looking statements.
Investor Verification Checklist
- Review Exhibit 99.1 for specific Q3 2017 revenue, net income, and cash flow figures not detailed in the 8-K text.
- Verify the final purchase price of the Premier Health Plan acquisition, as the $31.0 million figure is an estimate subject to membership-based adjustments.
- Monitor regulatory approval status for the transaction, as closing is contingent upon federal and state approvals.
- Assess the impact of the new Ohio-based Medicare Advantage and commercial business on Evolent's overall geographic and product diversification.
- Confirm the terms of the long-term provider arrangement and administrative services agreements to understand ongoing operational dependencies.